Insulet is recalling a portion of its Omnipod 5 insulin patch pumps over a problem that could lead to under-delivery of insulin. Devices from specific lots may have a small tear in the internal tubing ...

Stryker said the cyberattack that hit the company this week has disrupted its manufacturing and shipping operations. The medtech company released the information Thursday night in a statement posted ...

Along with the significant growth of genetic testing over the past two decades has come a rise in test fraud schemes targeting Medicare beneficiaries. Now, the Trump administration is requesting ...

The full scope of the impact, including operational and financial effects, is not yet known. Stryker does not have a timeline for full restoration of its systems.

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

The FDA sent the warning letter after an inspection of Exactech’s Sarasota, Florida, facility in July. At the time of the inspection, Exactech had not yet received court approval to sell its assets ...

The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.

Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.